Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think
05:50am, Tuesday, 15'th Aug 2023
Pfizer's revenue and earnings are falling, and the company faces a patent cliff. However, a wave of new product launches and business development deals should help ensure Pfizer's dividend remains saf
Pfizer gets FDA accelerated approval for multiple myeloma treatment
02:40pm, Monday, 14'th Aug 2023
A Pfizer Inc. PFE, +0.52% treatment for relapsed or refractory multiple myeloma has received accelerated approval from the U.S. Food and Drug Administration, the pharmaceutical company said Monday. Th
US FDA approves Pfizer's blood cancer therapy
02:16pm, Monday, 14'th Aug 2023
The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's therapy for treating patients with a type of blood cancer that is difficult to treat, the company said.
Pfizer, Moderna and Novavax developing jab to combat new Covid strain
09:32am, Monday, 14'th Aug 2023
Three US pharmaceutical companies, Pfizer Inc (NYSE:PFE), Moderna Therapeutics Inc (NASDAQ:MRNA), and Novavax Inc, are gearing up to release updated Covid-19 vaccines this autumn. The new jabs are de
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
01:48pm, Saturday, 12'th Aug 2023
There's a reason why many investors own one or more pharmaceutical stocks. This is a $1.2 trillion industry that is essential to the quality of life for many people.
2 High-Yield Dividend Stocks That Could Be Incredible Bargains
08:00am, Saturday, 12'th Aug 2023
High-yield dividend stocks can be powerful capital appreciation vehicles. Pfizer and AT&T stand out as two of the most compelling buys within this group right now.
Pfizer's Unexpected Strength: Bullish Case Emerges Amid New Covid-19 Wave
03:14pm, Friday, 11'th Aug 2023
On August 1, Pfizer released its financial report for the second quarter of 2023, which showed mixed results. Pfizer's revenue for the second quarter of 2023 was $18.28 billion, down 24.7% from the pr
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Does Pfizer Stock Belong in a Dividend Portfolio?
10:07am, Friday, 11'th Aug 2023
Pfizer's non-COVID business grew in the second quarter. It has numerous potential blockbusters in the works.
7 Dirt-Cheap Stocks to Buy in August
09:39pm, Thursday, 10'th Aug 2023
The allure of high-potential dirt-cheap stocks often tempts those looking for the next big win. This year has seen some market sectors skyrocket while others remain in the shadows, with untapped poten
These 10 medications are likely targets for Medicare price negotiations this fall
01:22pm, Thursday, 10'th Aug 2023
It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
7 Blue-Chip Stocks to Buy at an All-Time Low in August
09:49pm, Wednesday, 09'th Aug 2023
August started with a whimper, as the recent stock rally receded. After hitting an end-of-July $457 high, the SPDR S&P 500 ETF (NYSEARCA: SPY ) pared back its gains and fell about 2% with plenty of in
The 7 Best Sleeper Stocks to Buy in August
08:55pm, Wednesday, 09'th Aug 2023
While it's tempting on many levels to ride the flavors of the week, investors seeking long-term growth should consider the best sleeper stocks to buy. These securities feature very little investor int
3 Healthcare Stocks to Sell in August Before They Crash and Burn
06:35pm, Wednesday, 09'th Aug 2023
Healthcare continues to lag in the broader market. Year to date, the Standards and Practices (S&P) 500 Health Care index is down 2% versus a 17% gain in the benchmark S&P 500 index.
Fmr. FDA Commissioner Dr. Scott Gottlieb on diabetes drugs: Overall it's being used appropriately
11:09am, Wednesday, 09'th Aug 2023
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the growing interest in new diabetes drugs, with some showing promise for weight loss and heart disease prevention, the promise
